ghk cu tolerance or downregulation or desensitization ghk-cu loss of effectiveness over time The 5 on 2 off protocol for GH peptides is solving a problem that ghk-cu tolerance receptor downregulation desensitization

For now, consider it a budding field of study rather than an get younger magic bullet

Pharmacokinetic Profile Route of Administration Intravenous Dosing Frequency Once daily Route of Administration : used in animal studies as topical, intradermal, intra-articular, or intravenous applications Dosing Frequency : Once daily Half-Life : Varies depending on experimental design

3.5.2 When reviewing the PI3K/Akt pathway in Figure 3.7, notice the blunt arrow from Akt (in the phosphorylated state) to BCL2 associated agonist of cell death (BAD) protein

It is known that endogenous levels of GHK peptide naturally decline with age, from roughly 200 ng/ml at age 20 to 80 ng/ml at age 60 [3], and studies have shown that GHK-Cu can reset gene expression of human cells to a healthier state, which has led to breakthroughs in tissue regeneration and wound healing [4, 5, 6]

As shown in Table 1 , tripeptides differ significantly from larger peptides in several biological properties